NIAMS Clinical Trial Planning Grant (R34) | PAR 16 446

Opportunity Information: Apply for PAR 16 446

The NIAMS Clinical Trial Planning Grant (R34) is a discretionary NIH grant opportunity (Funding Opportunity Number PAR 16-446; CFDA 93.846) offered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Its purpose is to fund the upfront planning work needed before launching an investigator-initiated clinical interventional trial. Rather than paying for the full execution of a clinical trial, this mechanism supports the practical and regulatory groundwork that turns a promising clinical concept into a well-designed, feasible, and implementation-ready study.

This R34 is specifically aimed at helping investigators complete the essential planning, design, and documentation steps that typically must be in place before a trial can responsibly begin. In practice, this kind of planning can include finalizing the protocol and statistical analysis plan, confirming feasibility and recruitment strategies, developing detailed study procedures and manuals of operations, setting up data management and quality control plans, preparing safety monitoring approaches, and assembling the required trial documentation. The announcement emphasizes that the planned trial should be hypothesis-driven, built around clear milestones, and positioned to deliver high-impact results that align with the NIAMS research mission (which broadly covers arthritis and rheumatic diseases, musculoskeletal disorders, and skin diseases).

A key point in the structure of this opportunity is that the R34 is meant to be a preparatory step before seeking a larger implementation award. NIAMS notes that successful completion of the agreed-upon R34 milestones is recommended prior to submitting a U01 clinical trial implementation application, which would support actually running the study. In other words, the R34 functions like a bridge between early trial concept development and full clinical trial conduct, with the expectation that the planning period will produce a trial package that is ready to move forward without major redesign.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants listed include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (outside higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; regional organizations; eligible federal agencies; and U.S. territories or possessions. At the same time, it draws a firm boundary around foreign participation: non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed, meaning limited international involvement may be permissible when structured as a foreign component within an eligible U.S. applicant organization and justified under NIH policy.

From an administrative standpoint, the opportunity is categorized under Health as the funding activity area and uses the grant funding instrument. The source data notes an original closing date of 2020-01-14 and a creation date of 2016-09-23. The award ceiling and expected number of awards are not specified in the provided listing, which typically means applicants would need to consult the full FOA text or NIAMS/NIH guidance for budget limits, project period expectations, and any institute-specific constraints.

Overall, this R34 is best understood as targeted support for the often time-consuming and highly detailed pre-implementation phase of investigator-initiated clinical trials. It is designed for teams that have a strong clinical question and a plausible intervention plan, but who need dedicated resources to complete rigorous trial planning, lock down milestone-based readiness criteria, and assemble the full set of materials needed to compete for and successfully launch a subsequent NIAMS-supported implementation award such as a U01.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAMS Clinical Trial Planning Grant (R34)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846.
• This funding opportunity was created on 2016-09-23.
• Applicants must submit their applications by 2020-01-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for PAR 16 446

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: